Tricyclic antidepressant. Prepn: Hoffsommer et al., J. Org. Chem. 27, 4134 (1962); NL 6408512; E. I. Engelhardt, US 3922305 (1965, 1975 both to Merck & Co.). Alternative process: N. L. Wendler, US 3442949 (1969 to Merck & Co.). GC determn in plasma: J. E. Burch, J. Chromatogr. 308, 165 (1984). Determn in plasma or serum by radioimmunoassay: J. F. Sayegh, Neurochem. Res. 11, 193 (1986). HPLC determn in serum: O. V. Olesen et al., J. Chromatogr. B 746, 233 (2000). Pharmacokinetics: E. H. Rubin et al., J. Clin. Psychiatry 46, 418 (1985). Clinical pharmacogenetics: E. E. Kvist et al., Clin. Pharmacokinet. 40, 869 (2001). Clinical trial in post-stroke depression: J. R. Lipsey et al., Lancet 1, 297 (1984); in treatment-resistant depression: A. A. Nierenberg et al., J. Clin. Psychiatry 64, 35 (2003). Anticholinergic effect and clinical efficacy in urinary dysfunction: I. Nissenkorn et al., Eur. Urol. 12, 109 (1986). Comprehensive description: J. L. Hale, Anal. Profiles Drug Subs. 1, 233-247 (1972).
Antidepressant.
Antidepressant; Tricyclics